DC Field | Value | Language |
dc.contributor.author | Cornea, Natalia | |
dc.contributor.author | Tănase, Adrian | |
dc.contributor.author | Isac, Natalia | |
dc.contributor.author | Gaibu, Sergiu | |
dc.contributor.author | Visterniceanu, Dorian | |
dc.contributor.author | Evdochimov, Larisa | |
dc.contributor.author | Postolachi, Lilia | |
dc.contributor.author | Cepoida, Petru | |
dc.date.accessioned | 2020-05-09T16:23:09Z | |
dc.date.available | 2020-05-09T16:23:09Z | |
dc.date.issued | 2011 | |
dc.identifier.citation | CORNEA, N., TĂNASE, A., ISAC, N., et al. Modificările hematologice şi ale imunităţii celulare la pacienţii uremici cu diferite regimuri de tratament. In: Arta Medica. 2011, nr. 2(45), pp. 262-266. ISSN 1810-1852. | en_US |
dc.identifier.issn | 1810-1852 | |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/9285 | |
dc.description | Centrul Dializă şi Transplant Renal IMSP Spitalul Clinic Republican, Catedra Urologie şi Nefrologie Chirurgicală USMF “N.Testemiţanu”, Al V-lea Congres de Urologie, Dializă şi Transplant Renal din Republica Moldova cu participare internaţională (1-13 iunie 2011) | en_US |
dc.description.abstract | Summary. Patients with chronic kidney failure suffer from severe disorders of T and B lymphocyte function. Existing data confirm the absence of intrinsic defects of T and B cells, and shows major influence of urea and uremic toxins in the development of cellular immunodeficiency. In dialysis patients was determined predominance of T- suppressor lymphocytes (25.4% in study group) and 23.8% in the control group and values below the normal for total and active T lymphocytes (46.1% and 14.92 % in the study group, 46.8% and 14.9% in the control group, respectively). Hemodiafiltration led to a statistically significant decrease (p = 0.03) of T-suppressor lymphocytes - 18.7%, increase in T helper lymphocytes up to 41.6% (p = 0.003), and the total number of T lymphocytes, which increased from 46.1% to 60.0% (p = 0.004), number of active T cells increased from 14.92% to 21.2% (p = 0.02), T-morules - from 15.6% to 24.3% (p = 0.03). | en_US |
dc.language.iso | ro | en_US |
dc.publisher | Asociaţia chirurgilor “Nicolae Anestiadi” din Republica Moldova | en_US |
dc.subject.mesh | Kidney failure, Chronic--immunology | en_US |
dc.subject.mesh | Uremia--blood | en_US |
dc.subject.mesh | Uremia--immunology | en_US |
dc.subject.mesh | Immunity, Cellular | en_US |
dc.title | Modificările hematologice şi ale imunităţii celulare la pacienţii uremici cu diferite regimuri de tratament | en_US |
dc.title.alternative | Hematological and cellular immunity changes in patients with uremia undergoing different treatments | en_US |
dc.type | Article | en_US |
Appears in Collections: | Arta Medica Vol. 45 No.2, 2011 ediţie specială
|